Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Remdesivir

Gilead Cuts 2020 Sales Outlook As COVID-19 Drug Remdesivir Falls Short

Sales of the company's flagship HIV drugs rose 8% from a year earlier to $4.55 billion, as patient demand normalized following disruption related to the pandemic.

Read More

US FDA Approves Remdesivir, First Drug To Treat COVID-19 Patients

The drug was also recently touted by US President Donald Trump, whose physician confirmed he received it at Walter Reed National Military Medical Center as part of his own treatment for COVID-19 earlier this month

Read More

Four repurposed drugs have no effect on reducing mortality in COVID-19 cases: WHO

Four repurposed drugs have no effect on reducing mortality in COVID-19 cases: WHO

Read More

Doctor questions effects of medicine cocktail on Trump's brain

Doctor questions effects of medicine cocktail on Trump's brain

Read More

Trump to be administered final dose of Remdesivir on Tuesday at White House

Trump to be administered final dose of Remdesivir on Tuesday at White House

Read More

India presents 3,000 vials of Remdesivir to Myanmar as mark of commitment to assist Nay Pyi Taw in fight against COVID-19

India presents 3,000 vials of Remdesivir to Myanmar as mark of commitment to assist Nay Pyi Taw in fight against COVID-19

Read More

Dr Reddy's Launches Redyx (Remdesivir) In India For COVID-19 Treatment

Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of Covid-19 patients hospitalised with severe symptoms.

Read More

Karnataka govt issues norms for use of Remdesivir injections

Karnataka govt issues norms for use of Remdesivir injections

Read More

COVID-19: 3 Indian companies start supply of life-saving Remdesivir to Nepal

COVID-19: 3 Indian companies start supply of life-saving Remdesivir to Nepal

Read More

Nepal relies on India for life-saving Remdesivir drug

Nepal relies on India for life-saving Remdesivir drug

Read More

Zydus Cadila Launches Generic Version Of Remdesivir At Rs 2,800 Per Vial In India

Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing.

Read More

At Rs 2,800, Zydus Launches Remdac For Treatment Of COVID-19 In India

Managing Director Sharvil Patel said Remdac is the most affordable drug as the company would like to enable patients to have access to this critical drug in the treatment of COVID-19.

Read More

Gilead Raises Sales Outlook To Include COVID-19 Treatment Remdesivir

Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv.

Read More

COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir for 'restricted emergency use'

COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir for 'restricted emergency use'

Read More

Mylan announces commercial launch of its Remdesivir under brand name DESREMTM in India

Mylan announces commercial launch of its Remdesivir under brand name DESREMTM in India

Read More